drug development

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  

drug development
Mar 24, 2025, 19:01 | Blog
Victor Moreno: Huge congratulations to Dr. Emiliano Calvo for receiving the Phase 1
Victor Moreno, Director Clinical Research at START Madrid FJD, shared on LinkedIn: "Huge congratulations to…
Mar 11, 2025, 12:07 | Blog
Mark Lanasa: Honored to share the stage at SXSW with Pat Garcia-Gonzalez and Jeff Allen
Mark Lanasa, Chief Medical Officer of Solid Tumors at BeiGene, shared a post on LinkedIn:…
Dec 31, 2024, 03:37 | Blog
Matthew Pech: The failure of ex vivo gene therapy for sickle cell and the role of the TPP in the drug development process
Matthew Pech, Cofounder and VP of Newco, shared a post on LinkedIn: "The failure of…
Dec 12, 2024, 16:27 | Insight
Vivek Subbiah: Optimizing Tomorrow’s Drug Development with Project Optimus
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute (USA), shared…
Dec 10, 2024, 07:23 | Blog
James Crowley: Disappointments and failures are normal parts of medical research and drug development
James Crowley, Professor of Medicine emeritus at Brown University, shared a post by Wafik El-Deiry,…
Dec 9, 2024, 17:55 | Blog
Shahrin Ahmed: The treatment of multiple myeloma is being improved
Shahrin Ahmed, Medical Specialist oncology at Canadian Cancer Society and Associate Professor at Staffordshire University,…
Dec 4, 2024, 13:00 | Insight
Zhaohui Su: Embracing Real-World Data to Power Rare Cancer Research
"The study of cancer has evolved over the last two decades, driven primarily by genomic…
Dec 3, 2024, 15:29 | Insight
Nicholas Robert: Community Oncology Is Driving the Future of Cancer Research
"Precision medicine and targeted therapies have transformed the treatment of cancer for millions of patients…
Nov 26, 2024, 15:41 | Drugs
FDA approved a therapy for relapsed or refractory acute leukemia
Florida Cancer Specialists and Research Institute shared a post on LinkedIn: “On November 15, 2024,…
Nov 16, 2024, 11:27 | Blog
John V. Oyler: Committed to uniting the global community against cancer as BeOne
John V. Oyler, Founder, Chairman & CEO at BeiGene,  shared a post by BeiGene on LinkedIn, adding…
Nov 7, 2024, 07:14 | Blog
Jo Taylor: We Need Drug Developments to Overcome Access Inequality in the UK
Jo Taylor, Founder of After Breast Cancer Diagnosis, posted the following on X: “We need drug…
Nov 4, 2024, 15:59 | Blog
Toni Choueiri: Vas Narasimhan on drug development, pre-clinical science, strategies and real world data
Toni Choueiri, Director of the Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute, shared…
Oct 30, 2024, 09:47 | Insight
AI Hype and Reality - Three scientists go on a hike in Deep Origin
Three chemists head on a hike and discuss the realistic short term effects of AI…
Oct 26, 2024, 18:28 | Insight
SAGA Trial Achieves Full Recruitment: A Milestone in Cancer Research
The SAGA Trial has successfully completed full recruitment in just six months, marking a significant…
Oct 24, 2024, 16:04 | Blog
Saskia Litière opened the ENASymp24 with a focus on early drug development - EORTC
EORTC - European Organisation for Research and Treatment of Cancer shared on LinkedIn: “EORTC’s Scientific…
Oct 9, 2024, 10:46 | Blog
Wafik S. El-Deiry: Dr. Vivek Subbiah presents on AI’s impact in oncology research at AACR Grantee Summit
Wafik S. El-Deiry posted the following on LinkedIn: “Dr. Vivek Subbiah gives a fantastic presentation…
Oct 6, 2024, 06:31 | Blog
Join the NFCR Global Summit for Cancer Research and Entrepreneurship - AIM-HI Accelerator Fund
AIM-HI Accelerator Fund posted the following on LinkedIn: “The 2024 NFCR Global Summit and Award…
Oct 1, 2024, 15:57 | Insight
Measurable residual disease monitoring in AML
Top Biomedical Science shared on X: “Measurable residual disease monitoring in AML: Prospects for therapeutic…
Sep 29, 2024, 15:43 | Blog
Paolo Tarantino: The ratio of enrollment to industry-sponsored trials has doubled between 2008-2022
Paolo Tarantino shared the following on X: “Out in JCO: the ratio of enrollment to…
Sep 29, 2024, 15:36 | Insight
Estela Rodriguez: From an idea to a full conference
Estela Rodriguez shared on X: “Great to join Nagla Abdel Karim, Innova health at the…
Sep 28, 2024, 16:12 | Blog
Tanja Obradovic: AACR issues Cancer Progress Report 2024 with a focus on young adults and children
Tanja Obradovic shared the following on LinkedIn: “AACR just issued Cancer Progress Report 2024, which…
Sep 18, 2024, 23:19 | Insight
Estela Rodriguez: Looking forward to speak at Inova Health Symposium
Estela Rodriguez shared a post on X: “Looking forward to speak at Inova Health Symposium…
Sep 18, 2024, 11:58 | Blog
OncoInfluencers to Follow on Social Media: Dr. Vivek Subbiah
We are excited to highlight Dr. Vivek Subbiah as a prominent figure in the field…
Sep 17, 2024, 16:25 | Blog
Sanam Loghavi: Menin inhibitors in AML—exciting development and combination therapies
Sanam Loghavi posted the following on X: “Menin inhibitors are the most exciting class of…
Sep 10, 2024, 10:38 | Blog
Vivek Subbiah: Precision Dosing IS Precision Oncology
Vivek Subbiah shared a post on X: “Pleased to share the pre-proof version of the…
Sep 10, 2024, 10:28 | Blog
Matthew Herper: Facing cancer is hard -- even if you're someone who would change the way we treat cancer
Matthew Herper, Senior Writer, Medicine, and Editorial Director, Events at STAT, made the following post…
Sep 6, 2024, 15:57 | Insight
Vivek Subbiah: Editorial commentary on Project Optimus
Vivek Subbiah shared a post on LinkedIn: " Pleased to share the pre-proof version of the…
Sep 5, 2024, 14:03 | Blog
OncoInfluencers to Follow on Social Media: Dr. Lillian Siu
We are thrilled to spotlight Dr. Lillian Siu as a key figure in the oncology…
Sep 3, 2024, 13:39 | Blog
Herbert Loong: A very important resource for oncology drug developers globally
Herbert Loong shared a post on X: "A very important resource for oncology drug developers globally.…
Sep 2, 2024, 10:54 | Opinion
David Fajgenbaum: It's a common misconception that approval marks the peak of a drug's journey
David Fajgenbaum shared on X: “When a drug receives FDA approval, its research and development…
Aug 26, 2024, 21:22 | Blog
Vincent Rajkumar: Why are prescription drug prices far higher in the US than other developed countries
Vincent Rajkumar shared a post on X: “Why are prescription drug prices are far higher…
Aug 18, 2024, 20:28 | Drugs
Deepa Arora: US FDA Guidance on Dose Optimization for Oncology Drugs
Deepa Arora, Chief Executive Officer at Clinexel Life Sciences Private Limited, shared on LinkedIn: “Clinical…
Aug 17, 2024, 12:22 | Career
Edress Darsey: I’m starting a new position as Executive Director at Thermo Fisher Scientific
Edress (Horne) Darsey shared on LinkedIn: "I’m happy to share that I’m starting a new…
Aug 14, 2024, 01:53 | Insight
5 papers about lung cancer suggested by Stephen Liu
Stephen Liu, Head of Developmental Therapeutics at Georgetown Lombardi Comprehensive Cancer Center, shared a few…
Aug 11, 2024, 08:55 | Positive
Matthias Heinzel: It’s in our DNA
Matthias Heinzel, Member of the Executive Board and CEO of Life Science at Merck Group,…
Aug 10, 2024, 19:12 | Societies
Register for the SITC Immuno-oncology Drug Development Summit in Boston
Society for Immunotherapy of Cancer (SITC) shared on X: "Register for the SITC Immuno-oncology Drug…
Aug 6, 2024, 14:55 | Blog
Stephen Liu: Discussion on the emergence of immunotherapy in lung cancer
Stephen Liu shared on X: "Highlighting one of my favorite episodes of the IASLC podcast,…
Aug 5, 2024, 10:25 | Insight
5 papers about Lung Cancer suggested by Stephen Liu
Stephen Liu, Head of Developmental Therapeutics at Georgetown Lombardi Comprehensive Cancer Center, shared a few…
Aug 3, 2024, 10:13 | Drugs
Harpreet Singh: ODAC vote marks a pivotal moment in oncology drug development
Harpreet Singh, Chief Medical Officer at Precision For Medicine, shared on LinkedIn: "The recent FDA…
Jul 31, 2024, 03:40 | Blog
Applications for the FDA-AACR Oncology Educational Fellowship are still open
AACR (American Association for Cancer Research) shared a post on LinkedIn: ''The FDA-AACR Oncology Educational…
Jul 29, 2024, 09:20 | Insight
PD-L1 and durvalumab after chemoradiation for stage III NSCLC in Netherlands Cancer Registry
Stephen Liu shared on X about a recent paper by Damhuis Ram et al. titled…
Jul 28, 2024, 14:38 | Drugs
Elad Sharon: Contribution of effect is an under appreciated and essential part of drug development
Elad Sharon, Clinical and Translational Director of Dana-Farber Cancer Institute, shared a post by FDA Oncology…
Jul 26, 2024, 12:17 | Blog
Ruben Mesa's work on how to keep up the pace of timely drug development - Levine Cancer
Levine Cancer shared a post on X: "Survivors are living longer thanks to new anticancer…
Jul 24, 2024, 02:14 | Blog
Jing Ping Yeo: Establishment of the Asia Pacific Oncology Drug Development Consortium
Jing Ping Yeo, Head of transformation, Operational Enablers, Commercial Excellence, Accelerate Growth at George Clinical,…
Jul 21, 2024, 15:37 | Insight
Neoadjuvant osimertinib for resectable EGFR NSCLC
Stephen V Liu shared on X a recent paper by Collin M. Blakely et al.…
Jul 20, 2024, 16:22 | Blog
Oncoinfluencers to Follow on Social Media: Dr. Stephen Liu
At OncoDaily, we are excited to feature Dr. Stephen Liu, a preeminent thoracic oncologist, as…
Jul 14, 2024, 06:45 | Blog
Herbert Loong: Looking forward to the first APODDC forum next Friday
Herbert Loong shared a post on X: "Looking forward to our first APODDC forum next…
Jul 8, 2024, 12:29 | Drugs
Jennifer Buell: NCI Announces Availability of Botensilimab for Clinical Development
Jennifer Buell, President and Chief Executive Officer of MiNK Therapeutics, shared on X: “NCI Announces…
Jul 7, 2024, 09:58 | Insight
Shilpa Gupta: Vivek Subbiah shares his vision and tumor agnostic drug development in Athens
Shilpa Gupta shared a post on X: “The amazing Vivek Subbiah shares his phenomenal vision statement…
Jul 6, 2024, 15:02 | Blog
FDA-AACR Oncology Educational Fellowship's impact on participants
American Association for Cancer Research shared a post on LinkedIn: “An article in Clinical Cancer…
Jul 6, 2024, 14:44 | Insight
BAX protein's role in cell death, a promising target for cancer therapy - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn: “For years, researchers have explored BAX protein's…
Jul 6, 2024, 02:00 | Blog
The NCI PREVENT Cancer Preclinical Drug Development Program - NCI Division of Cancer Prevention
NCI Division of Cancer Prevention shared on LinkedIn: “Application deadline Monday! Are you someone actively…
Jul 2, 2024, 14:53 | Blog
MD Anderson and Sibylla Biotech announce collaboration to discover and develop small-molecule protein degraders
Sibylla’s PPI-FIT technology joins with MD Anderson’s drug development resources and expertise to create protein…
Jun 28, 2024, 15:18 | Blog
Elevate your drug development programs - The START Center for Cancer Research
The START Center for Cancer Research recently shared a post on LinkedIn: “Are you attending…
Jun 14, 2024, 00:36 | Blog
Kai Tian Fan: Read the latest edition of Pharma Insights
Kai Tian Fan, Technical Marketing Manager at Croda, shared a post on LinkedIn: "Read now…
Jun 12, 2024, 12:13 | Blog
Stacy Hurt: Join us at DIA2024
Stacy Hurt shared a post on X/Twitter: ''Please join us at DIA2024 where I'll be speaking…
Jun 12, 2024, 04:56 | Blog
The Rising Tide: Trends and Challenges of Lung Cancer in Asia - The Lancet
The Lancet made the following post on LinkedIn: "Join our upcoming Lancet Webinar, during which…
Jun 12, 2024, 02:27 | Blog
FDA and CTTI To Host a Public Workshop on AI in Drug and Biological Product Development
On Tuesday, August 6, 2024 from 10 AM to 5:30 PM EDT, the FDA and…
Jun 10, 2024, 10:26 | Career
Apply to FDA-AACR Oncology Educational Fellowship by August 1
American Association for Cancer Research recently shared a post on LinkedIn: "The FDA-AACR Oncology Educational…
Jun 4, 2024, 13:28 | Dialogues
Oncothon: Pediatric Cancer Research with Cesare Spadoni
Oncothon is a telethon spanning 24 hours, dedicated to gathering donations for childhood cancer research.…
Jun 4, 2024, 09:59 | Blog
Marco Gymnopoulos: Looking for an associate director for my solid tumor ADC portfolio team at AstraZeneca
Marco Gymnopoulos, Director ADC Portfolio at AstraZeneca, shared a post on LinkedIn: ''Hiring: I am…
May 31, 2024, 22:07 | Insight
Ahmad Tarhini: Employing a machine learning framework to molecular data from patients with melanoma
Ahmad Tarhini, Director of Cutaneous Clinical and Translational Research at Moffitt Cancer Center, shared on…
May 26, 2024, 14:54 | Dialogues
Oncothon: Pediatric oncology with Maria Babak, Jemma Arakelyan
Oncothon is a telethon spanning 24 hours, dedicated to gathering donations for childhood cancer research.…
May 25, 2024, 09:42 | Societies
SCRI Oncology Partners introduces its members
Sarah Cannon Research Centre (SCRI) Oncology Partners shared on LinkedIn: With our new LinkedIn page, we…
May 24, 2024, 13:18 | Blog
Thomas Biegi: I had the honor of participating in a panel discussion during The Leukemia and Lymphoma Society’s event 'TAP Into a Cure'
Thomas Biegi, Senior Vice President, Head of Corporate Affairs at MorphoSys, made the following post…
May 20, 2024, 11:18 | Drugs
Elisa Agostinetto: Our review on emerging treatments for HER2+ breast cancer
Elisa Agostinetto, Clinical Research Fellow at Institute Jules Bordet, shared a post on LinkedIn: “Now…
May 19, 2024, 13:37 | Insight
Charles Chen: Check out our recent publication about PK/PD framework for ADC!
Charles Chen, Senior Director of Clinical Pharmacology and Translational Sciences at Zymeworks, shared a post…
May 19, 2024, 06:05 | Insight
Herbert Loong: Our latest recommendations for NTRK fusion testing and management in lung cancer
Herbert Loong shared on X: "We have recently published our latest recommendations for NTRK fusion…
May 16, 2024, 10:07 | Blog
Melissa Johnson: Thrilled to help launch SCRI Oncology Partners’ LinkedIn page!
Melissa Johnson, Director of Lung Cancer Research at Sarah Cannon, shared a post by SCRI…
May 16, 2024, 01:44 | Blog
Live from Project In The Spotlight session with ALADDIN - SIOP Europe
SIOP Europe shared a post on X: "Live from Project In The Spotlight session with…
May 14, 2024, 15:00 | Drugs
Ravi Karra discusses overcoming challenges in early phase drug development for solid tumors - Advanced Clinical
Advanced Clinical shared on LinkedIn: . "Innovative trial designs and advanced imaging modalities could address…
May 14, 2024, 11:07 | Blog
Tanja Obradovic: At ASCO 2024 at the ICON plc booth we share thoughts on latest in cancer treatment innovation
Tanja Obradovic shared a post by ICON plc on LinkedIn, adding: ''This year we are certain…
May 13, 2024, 13:43 | Blog
Hemali Batra-Sharma: Please fill out this anonymous 5-minute survey to assess gaps in fellowship training
Hemali Batra-Sharma, Hematology/Oncology Fellow at UC San Diego Health, shared on X: "Hematology/Oncology fellows, I'm…
May 11, 2024, 11:32 | Blog
Vivek Subbiah: Future of early-phase drug development and precision medicine is bright at Gustave Roussy Cancer Center!
Vivek Subbiah shared a post by Adrien Mouren, on X and added: "Future of early-phase…
May 10, 2024, 19:05 | Dialogues
Oncothon: Pediatric Cancer Drug Development
Oncothon is a telethon spanning 24 hours, dedicated to gathering donations for childhood cancer research.…
May 8, 2024, 14:22 | Career
Esosa Omoregie: Here’s to taking another step forward in contributing to innovative healthcare solutions
Esosa Omoregie, Graduate Research Assistant, Department of Biology at Georgia Southern University, shared on LinkedIn:…
Apr 30, 2024, 16:02 | Opinion
Lernik Ohanjanian: AI as a transformative tool to improve cancer patient outcomes
Lernik Ohanjanian, Senior Medical Director at Miltenyi Biomedicine, shared on LinkedIn: "We are standing on…
Apr 26, 2024, 16:34 | Dialogues
Oncothon: ASCO And Cancer Drug Development
Oncothon is a telethon spanning 24 hours, dedicated to gathering donations for childhood cancer research.…
Apr 25, 2024, 20:52 | Dialogues
Oncothon: Pediatric Cancer Drug Development
Oncothon is a telethon spanning 24 hours, dedicated to gathering donations for childhood cancer research.…
Apr 23, 2024, 10:07 | Insight
Ashley Magargee: Fortunate to have leading computational biology experts like Aviv Regev advancing our understanding of cancer like never before
Ashley Magargee, Chief Executive Officer at Genentech, shared on LinkedIn: "We’re fortunate to have leading…
Apr 22, 2024, 17:41 | Blog
Zach Taft: It was truly an honor to moderate the Bio-IT conference panel discussion
Zach Taft, Co-Founder of the Clinical Research Innovation Consortium at Memorial Sloan Kettering Cancer Center,…
Apr 19, 2024, 07:18 | Blog
Ruben Mesa: Over 20 years of cancer collaboration with shared biomedical engineering program between VT and Wake Forest University School of Medicine!
Ruben Mesa, President of Atrium Health Levine Cancer, shared on LinkedIn: “Deeply exciting visit to…
Apr 14, 2024, 13:10 | Blog
Herbert Loong: Had opportunity to welcome colleagues from Bayer AG Company
Herbert Loong, Clinical Associate Professor at The Chinese University of Hong Kong, shared a post…
Apr 13, 2024, 11:41 | Insight
Nico Gagelmann: Methodological challenges in the development of endpoints for myelofibrosis clinical trials
Nico Gagelmann, Chair of CAR-T for plasma cell disorder committee and Chair Trainee Committee at…
Mar 30, 2024, 11:05 | Dialogues
The Comfort Corner #1: Dialogue with Matti Aapro, hosted by Martin Harutyunyan
Welcome to "The Comfort Corner" - a palliative care series that brings together medical professionals…
Mar 29, 2024, 06:23 | Blog
Tara Frenkl: What an incredible experience it was to be on a panel with our guests Stacy Hurt and Amy McKee
Tara Frenkl, Senior Vice President and Head of Oncology Development at Bayer, shared on LinkedIn:…
Mar 22, 2024, 15:57 | Dialogues
OncoInfluencers: Dialogue with Lillian L. Siu, hosted by Gevorg Tamamyan
Join us for an exciting new episode of “OncoInfluencers”, hosted by Dr. Gevorg Tamamyan. In…
Mar 3, 2024, 16:42 | Blog
Vivek Subbiah: Thrilled to announce a groundbreaking - AstraZeneca and Sarah Cannon Docs collaboration
Vivek Subbiah shared a post on X: "Exciting News in Clinical Trials! Thrilled to announce…
Feb 26, 2024, 15:38 | Blog
ALADDIN Education: Applications for the ALADDIN Education 360° rotation with the European Medicines Agency are now open
ALADDIN Education posted on LinkedIn: "Interested in gaining practical experience in regulatory affairs and drug…
Feb 19, 2024, 18:18 | Blog
Anas Younes: We are developing more than one drug for the same disease indication, so we can build future combination regimens
Anas Younes posted on LinkedIn: ''Our hematology team spent the last 3 days reviewing our…
Feb 16, 2024, 05:40 | Blog
Justin Stebbing: You're all invited to an event about teamwork and collaboration at breakneck speed
Justin Stebbing shared a post on LinkedIn: "You're all invited to an event about teamwork and…
Feb 4, 2024, 22:50 | Blog
Tara Frenkl: Couldn't agree more that collaboration and teamwork are key
Tara Frenkl, Senior Vice President, Head of Oncology Development at Bayer, shared on LinkedIn: "Thanks…
Feb 1, 2024, 05:27 | Blog
Shweta Maniar: After attending the J.P. Morgan Healthcare Conference in San Francisco, I want to share some of my key takeaways
Shweta Maniar, Global Director, Healthcare and Life Sciences at Google, shared on their LinkedIn: ''After…
Jan 12, 2024, 17:31 | Blog
Karin Hoelzer: I was honored to represent the National Organization for Rare Disorders and the rare community in this important discussion
Karin Hoelzer, Director of Policy and Regulatory Affairs at NORD shared on LinkedIn: “Drug development…
Dec 19, 2023, 18:00 | Insight
Vivek Subbiah: The evolution of basket trials in cancer drug development
Vivek Subbiah shared on X/Twitter: "Revolutionizing cancer drug development: Harnessing the potential of basket trials…
Dec 12, 2023, 17:55 | Opinion
Isabel Mestres: Are we investing smartly?
Isabel Mestres, CEO at City Cancer Challenge Foundation, shared the following post on LinkedIn: ''Innovation…
Dec 10, 2023, 18:07 | Blog
Nathan Vardi: I traveled down to Maryland and spent the day at the FDA
Nathan Vardi, Managing Editor, Enterprise at MarketWatch, shared on LinkedIn: "Not long after my book, FOR…
Nov 27, 2023, 17:33 | Opinion
Rescuing drugs and the multi-stakeholder approach for drug development - ACCELERATE Multi-Stakeholder Platform
ACCELERATE Multi-Stakeholder Platform shared on their LinkedIn page: "Better therapies for childhood cancer remain an…
Jul 6, 2023, 04:38 | Blog
This WECAN Academy was just amazing, a very unique, patient-driven, cross-cancer training event with such amazing advocates from so many counties
In a post by Jan Geissler on Linkedin, it says, "The four days of the WECAN Academy…
Jun 25, 2023, 16:21 | Drugs
Are we entering a ‘golden age’? - Daniel Stover
Are we entering a ‘golden age’? -For discovery, drug development, & new treatments perhaps an…
All: 100 Posts: 1 - 100
Special Coverage